Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CUPRIPEN 250 CAPSULE 250 mg

Approval Number

SIN08173P

Drug Name

CUPRIPEN 250 CAPSULE 250 mg

Product Name

CUPRIPEN 250 CAPSULE 250 mg

Approval Date

May 17, 1995

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

M01CC01

ATC Item Name

penicillamine

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

LABORATORIOS RUBIO SA

Active Ingredients

Ingredient Name

D-PENICILLAMINE

Strength

250 mg

Drug MonographPenicillamine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy